연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3805. Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial.
Marabelle A, O'Malley DM, Hendifar AE, Ascierto PA, Motola-Kuba D, Penel N, Cassier PA, Bariani G, De Jesus-Acosta A, Doi T, Longo F, Miller WH Jr, Oh DY, Gottfried M, Yao L, Jin F, Gozman A, Maio M.
Nat Cancer. 2025 Feb;6(2):253-258.
Link
3804. INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.
Pavlakis N, Shitara K, Sjoquist K, Martin A, Jaworski A, Tebbutt N, Bang YJ, Alcindor T, O'Callaghan C, Strickland A, Rha SY, Lee KW, Kim JS, Bai LY, Hara H, Oh DY, Yip S, Zalcberg J, Price T, Simes J, Goldstein D.
J Clin Oncol. 2025 Feb;43(4):453-463.
Link
3803. Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer.
Abegesah A, Oh DY, Lim K, Fan C, Chen C, Kim C, Wang J, Xynos I, Zotkiewicz M, Ren S, Phipps A, Gibbs M, Zhou D.
Cancer Chemother Pharmacol. 2025 Jan 17;95(1):23.
Link
3802. Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer.
Meric-Bernstam F, Hollebecque A, Furuse J, Oh DY, Bridgewater JA, Anderson B, Hangai N, Wacheck V, Goyal L.
Future Oncol. 2025 Jan;21(2):139-150.
Link
3801. IL-10 sensing by lung interstitial macrophages prevents bacterial dysbiosis-driven pulmonary inflammation and maintains immune homeostasis.
Kim SH, White Z, Gainullina A, Kang S, Kim J, Dominguez JR, Choi Y, Cabrera I, Plaster M, Takahama M, Czepielewski RS, Yeom J, Gunzer M, Hay N, David O, Chevrier N, Sano T, Kim KW.
Immunity. 2025 May 13;58(5):1306-1326
Link
3800. Preventable cancer cases and deaths attributable to alcohol consumption in Korea from 2015 to 2030
Sung S, An J, Jung J, Lee HS, Moon S, Kim I, Lee JE, Shin A, Jee SH, Kweon SS, Shin MH, Park S, Ryu S, Yang SY, Choi SH, Kim J, Yi SW, Choi YJ, Hong Y, Lee S, Lim W, Kim K, Park S, Im JS, Seo HG, Ko KP, Park SK.
Epidemiol Health. 2025;47:e2025009
Link
3799. Long-Term Survivorship after Gastrectomy or Endoscopic Resection for Gastric Cancer Using Nationwide Real-World Data
Woo HT, Kang SH, Baek JY, Yoo M, Park YS, Kim N, Lee DH, Kim HH, Shin A, Suh YS.
J Am Coll Surg. 2025 Oct 1;241(4):682-693.
Link
3798. Association of Elevated Serum Triglycerides with Colorectal Cancer Risk: Findings from a Large-scale Prospective Cohort of Korean Adults
Min S, Lee H, Cho S, Jeong SY, Shin A, Kang D.
Cancer Prev Res (Phila). 2025 Aug 13:OF1-OF11.
Link
3797. Genome-wide interaction study of physical activity and genetic susceptibility on colorectal cancer using UK biobank data
Cho S, Shin A.
Sci Rep
. 2025 Aug 18;15(1):30180.
Link
3796. Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study
Kim DH, Kong JH, Hong J, Byun JM, Shin DY, Koh Y, Kim I, Park J, Do YR, Kim JA, Kim WS, Shin HJ, Yoon SS
Ther Adv Hematol. 2025 Jul 11;16:20406207251349361
Link